Details for New Drug Application (NDA): 080140
✉ Email this page to a colleague
NDA 080140 describes LANIAZID, which is a drug marketed by Lannett and Chartwell Molecular and is included in three NDAs. It is available from two suppliers. Additional details are available on the LANIAZID profile page.
The generic ingredient in LANIAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
The generic ingredient in LANIAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
Summary for 080140
| Tradename: | LANIAZID |
| Applicant: | Chartwell Molecular |
| Ingredient: | isoniazid |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080140
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
